Abalone Bio的动态

?? Exciting Opportunity Alert! ?? Join us today at #BI02024 in the BioProcess Theater at 2:00 p.m. for an insightful session on "Seamless Viral Vector Tech Transfer at Any Phase." A successful viral vector tech transfer demands expertise, precision, and a systematic approach to minimize program impact and ensure a seamless continuity of supply. At CRL, we understand the critical importance of a smooth transition, especially in the dynamic field of bioprocessing. Discover how we at CRL adapt and expedite your gene therapy journey with our quality expertise and efficiency. By choosing a CDMO that provides integrated capabilities under one roof, you can maintain full control over your project and steer clear of unnecessary delays. Don't miss this opportunity to learn how we can help you navigate the complexities of viral vector tech transfer smoothly and efficiently. See you there! ?? #bioprocessing #genetherapy #CDMO #innovation #biotech

Syngene is featured in 'CXOToday' magazine! The article highlights how Syngene's strategic vision has helped us navigate challenges and achieve success. Read the full story:??? https://lnkd.in/gfeYDvA8 #CXO #Syngene

Check out Do Kim's latest report on Vivos 2Q24 earnings results. Read about how their new distribution model and strong patient demand for its OSA treatments is setting the stage for a significant revenue surge in 2H24. #VVOS #Biotech #SleepApnea #SmallCapStocks #InvestorRelations #EquityResearch #WTR #WaterTowerResearch https://lnkd.in/ez635UUE

Daniel Levine speaks with Unnatural Products Inc. CEO Cameron Pye Some 70 percent of potential therapeutic targets are believed to be beyond the reach of conventional small molecule therapies or biologics. #Macrocyclic peptides offer a way to get at elusive targets while providing desirable characteristics of both small molecule drugs and biologics. They offer oral bioavailability, can permeate cells, and engage complex targets with specificity. Unnatural Products is harnessing AI to create synthetic macrocyclic peptides to pursue previously undruggable targets. We spoke to Cameron Pye, CEO and co-founder of Unnatural Products, about how these peptides can target proteins that traditional therapies cannot reach, the engineering process for the company’s synthetic macrocyclic peptides, and their potential to lead to new innovative therapies for a range of conditions from #cancer to #obesity. Listen to the podcast here: ???? https://lnkd.in/efdJtJK3

?? Are you attending Swiss Biotech Day? Connect with our delegates to start a conversation and discover how we can assist you with our agile and holistic biotech solutions! #biotech #swissbiotechday2024 Swiss Biotech Association

?? HyBryte? Sets New Standards in CTCL Care! Soligenix's (Nasdaq: SNGX) latest study shows HyBryte? outperforming Valchlor? in CTCL treatment, with continued improvement post-treatment and no safety concerns reported. ?? ?? Read the full study here: https://lnkd.in/eiMh7T_g #CTCL #Biotech #BiotechNews #CancerResearch #FDA #FinancialNews #CapitalMarkets

What are the challenges facing European biotech right now? Ekin Ece Erkan Kaplan shares her perspectives for this IBTV Movers & Shakers interview at Advanced Therapies Europe ?? #ATE24 #Biotech

This was quite a track record of performance for Cybin over the past year: - Positive phase 2 safety and efficacy readout for CYB003 as an adjunctive treatment for MDD - Around 75% of MDD patients in remission after just two doses - sustained for at least 4 months - Breakthrough Therapy Designation awarded to CYB003 by FDA - Successful recruitment of 30 sites for an upcoming phase 3 study of CYB003 in MDD this summer - Closing and integration of the Small Pharma team, along with programs and IP - Acceleration of CYB004 IM formulation aimed at delivering a 90 minute experience - Initiation of a phase 2 study of CYB004 in GAD with top line results expected around year end 2024

Is Revio your platform of choice for Long Read Sequencing? Check out the LightBench as it effectively maximises the benefits from this long read sequencer. #PacBio #LightBench #RangerTechnology #Sizeselection

#Turbocycler 3 is the newly added member of the #Turbocycler family! Watch the video.